Department of Breast Imaging.
Department of Breast Surgical Oncology.
Clin Breast Cancer. 2022 Feb;22(2):e158-e166. doi: 10.1016/j.clbc.2021.05.013. Epub 2021 Jun 3.
Breast conservation surgery (BCS) is the treatment of choice for unifocal, early-stage breast cancer. The ability to offer BCS to a wider subset of patients, including those with multifocal/multicentric cancer as well as extensive ductal carcinoma in situ, has emerged over time, especially in those undergoing joint oncoplastic reconstruction and those treated with neoadjuvant therapy. However, localization techniques using multiple radioactive seeds for bracketing in this patient subset have not been validated.
A single-institution retrospective review was conducted of all patients with breast cancer who underwent BCS, guided by multiple bracketed iodine I 125 radioactive seeds between January 2014 and April 2017.
Bracketing of breast cancer using 2 or more radioactive seeds was performed in 157 breasts in 156 patients. Negative margins were achieved in 124 of 157 (79%) breasts, including 33 cases (21%) that underwent targeted margin reexcision at the time of surgery after intraoperative, multidisciplinary margin assessment. Thirty-three cases (21%) resulted in close or positive margins, of which 11 (7%) and 10 (6.4%) underwent completion mastectomy or repeat lumpectomy, respectively. Twelve patients (7.6%) did not undergo reexcision. En bloc resection was successful in 134 of 157 (85.4%) lumpectomies. Eighty-nine percent of the procedures were coupled with oncoplastic reconstruction.
Bracketing techniques using multiple radioactive seeds expands the indications for breast conservation therapy in patients who would have traditionally required mastectomy. Intraoperative margin assessment improves surgical and pathologic success. Larger defects created by multifocal resection are optimally managed in concert with oncoplastic reconstruction to minimize asymmetries and aesthetic defects.
保乳手术(BCS)是治疗单发、早期乳腺癌的首选方法。随着时间的推移,能够为更多的患者提供 BCS,包括多灶/多中心癌以及广泛的导管原位癌患者,这种情况已经出现,特别是在接受联合肿瘤整形重建和新辅助治疗的患者中。然而,对于这一患者群体,使用多个放射性种子进行多点定位的定位技术尚未得到验证。
对 2014 年 1 月至 2017 年 4 月期间,在一家机构内接受 BCS 的所有乳腺癌患者进行了回顾性研究,这些患者均采用多个碘 I 125 放射性种子进行多点定位。
在 156 例患者的 157 个乳房中进行了 2 个或更多放射性种子的定位。157 个乳房中有 124 个(79%)达到了阴性切缘,包括 33 例(21%)在术中多学科切缘评估后,进行了靶向切缘再次切除。33 例(21%)的切缘接近或阳性,其中 11 例(7%)和 10 例(6.4%)分别进行了全乳房切除术或再次乳房切除术。12 例(7.6%)患者未进行再次切除。在 157 个肿块切除术中有 134 个(85.4%)整块切除成功。89%的手术与肿瘤整形重建相结合。
使用多个放射性种子的多点定位技术扩大了传统上需要乳房切除术的患者进行保乳治疗的适应证。术中切缘评估提高了手术和病理成功率。多灶切除造成的较大缺陷,通过与肿瘤整形重建相结合,可优化管理,最大限度地减少不对称和美学缺陷。